Literature DB >> 16079528

Investigation of drug-cyclodextrin complexes by a phase-distribution method: some theoretical and practical considerations.

Már Másson1, Birna Vigdís Sigurdardóttir, Kristján Matthíasson, Thorsteinn Loftsson.   

Abstract

The purpose of the study was to evaluate an octanol-water phase distribution method for investigation of drug/cyclodextrin (D/CD) complexes and to compare stability constant values obtained by this method to values obtained by the phase solubility method. A general equation for determination of 1 : 1 D/CD complex stability constant (K1 : 1) from the slope of a phase-distribution diagram (a diagram of the reciprocal of the apparent partition coefficient vs. the total CD concentration) was derived. The equation accounted for the possible inclusion of the organic solvent in the CD cavity and the gradual saturation of the CD binding with increasing concentration of the guest compound. This method was used to determine K1 : 1 for 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) complexes of hydrocortisone, prednisolone, diazepam, beta-estradiol and diethylstilbestrol. These values were comparable to K1 : 1 values determined by the phase-solubility method. The phase-distribution method could also be applied to determine stability constants for the neutral and ionic forms of the weakly acidic drugs, naproxen and triclosan and the weakly basic drug lidocaine. The phase-distribution method is a very versatile and fast method and has the advantage, compared to the phase-solubility method, that it only requires very small drug samples. Thus, this method would be suitable for screening of new drug candidates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079528     DOI: 10.1248/cpb.53.958

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  6 in total

1.  High-throughput phase-distribution method to determine drug-cyclodextrin binding constants.

Authors:  Zhi Chen; Dujuan Lu; Stephen G Weber
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

2.  NMR studies of the inclusion complex of cloprostenol sodium salt with beta-cyclodextrin in aqueous solution.

Authors:  Hyun Suk Whang; Franck A P Vendeix; Hanna S Gracz; John Gadsby; Alan Tonelli
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

3.  Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila.

Authors:  Jose Agosto; James C Choi; Katherine M Parisky; Geoffrey Stilwell; Michael Rosbash; Leslie C Griffith
Journal:  Nat Neurosci       Date:  2008-01-27       Impact factor: 24.884

4.  Determination of binding constants by affinity capillary electrophoresis, electrospray ionization mass spectrometry and phase-distribution methods.

Authors:  Zhi Chen; Stephen G Weber
Journal:  Trends Analyt Chem       Date:  2008-10       Impact factor: 12.296

5.  Towards the rational design of novel drugs based on solubility, partitioning/distribution, biomimetic permeability and biological activity exemplified by 1,2,4-thiadiazole derivatives.

Authors:  T V Volkova; I V Terekhova; O I Silyukov; A N Proshin; A Bauer-Brandl; G L Perlovich
Journal:  Medchemcomm       Date:  2016-10-28       Impact factor: 3.597

6.  Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study.

Authors:  Matthew R Durk; Nicholas S Jones; Jia Liu; Karthik Nagapudi; Chen Mao; Emile G Plise; Susan Wong; Jacob Z Chen; Yuan Chen; Leslie W Chinn; Po-Chang Chiang
Journal:  Clin Pharmacol Ther       Date:  2020-07-18       Impact factor: 6.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.